Skip to main content

Table 3 Information about given NAC and hemoglobin values in the 87 patients who received NAC

From: A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy

Variable

Total (n = 87)

NAC treatment

 

 MVAC

53 (60.9)

 HD-MVAC

21 (24.1)

 Cisplatin-Gemzar

6 (6.9)

 MVEC

5 (5.7)

 Carboplatin-Gemzar

1 (1.1)

 MVAC + Taxotere

1 (1.1)

Hemoglobin level (g/L)

 

 Prior to NAC

127 (117–127)

 Prior to surgery

115 (107–123)

 Anemic prior to NAC

48 (55.2)

 Anemic prior to surgery

70 (80.5)

 Number of days from last NAC to surgery

35 (29–42)

  1. Data are shown as median (IQR) or n (%)